Overview
LSTA market data
Price History
LSTA price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.91 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.90 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -4,478.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.99 – $5.07 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $10.5M · P/B 1.10 · P/S 61.49.
Company News
Lisata shares are trading higher after the company announced it is pursuing damages through litigation over Kuva’s breached merger agreement, reviewing strategic alternatives, and cutting costs with a major workforce reduction to preserve cash.Benzinga · Aug 4, 2026, 6:27 PM
Lisata Therapeutics Announces Suit Against Kuva Labs Seeking Damages And $2M Termination Fee; Cuts Approximately 72% Of Full-Time EmployeesBenzinga · Aug 4, 2026, 11:14 AM
Lisata Therapeutics shares are trading lower after the company announced it has terminated its merger agreement with Kuva Labs.Benzinga · Jul 24, 2026, 5:54 PM
Lisata Therapeutics Terminates Merger Agreement With Kuva Labs; Termination Due To Kuva Labs' Failure To Obtain Financing, Accept Tendered Shares; Board To Carry Out Strategic Options Including Asset SaleBenzinga · Jul 24, 2026, 4:20 PM
8-K filing — LISATA THERAPEUTICS, INC. (LSTA)SEC EDGAR · Jul 24, 2026, 4:15 PM
Lisata Therapeutics Stock Falls After Hours: Here's WhyBenzinga · Jul 22, 2026, 5:03 AM
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.Benzinga · Jun 10, 2026, 12:15 PM
Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving PremarketBenzinga · Jun 1, 2026, 10:01 AM
HC Wainwright & Co. Downgrades Lisata Therapeutics to NeutralBenzinga · May 15, 2026, 3:50 PM
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: KalVista Pharmaceuticals, Inc. (Nasdaq – KALV), Thermon Group Holdings, Inc. (NYSE – THR), Sila Realty Trust, Inc. (NYSE – SILA), Lisata Therapeutics, Inc. (Nasdaq – LSTA)Globenewswire Inc · May 14, 2026, 6:15 PM